Picture of BioNxt Solutions logo

BNXT BioNxt Solutions Balance Sheet

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for BioNxt Solutions, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash
Cash and Short Term Investments1.350.1360.3640.0320.055
Net Total Accounts Receivable
Net Total Receivables0.5460.4590.2830.0610.08
Total Inventory
Prepaid Expenses
Total Current Assets2.70.6910.7190.1640.323
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment1.130.9210.5490.4060.219
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets9.731.611.270.5690.592
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities5.452.026.556.885.97
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Liabilities8.065.746.558.439.96
Common Stock
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity1.67-4.13-5.28-7.86-9.37
Total Liabilities & Shareholders' Equity9.731.611.270.5690.592
Total Common Shares Outstanding